51 h. ago Junshi Biosciences Announces 2024 Full Year Financial Results and Provides Corporate Updates

SHANGHAI, March 28, 2025 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2024 and provided corporate updates. FINANCIAL HIGHLIGHTS Total revenue of Junshi Biosciences was […]

Other

53 h. ago Partners Value Investments Inc. Announces 2024 Annual Results

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Partners Value Investments Inc. (the “Company”, TSX: PVF.WT, PVF.PR.V) announced today its financial results for the year ended December 31, 2024. All amounts are stated in U.S. dollars. The Company recorded net loss of $3.8 billion for the year ended December 31, 2024, compared to $333 million in […]

Culture

53 h. ago Partners Value Investments L.P. Announces 2024 Annual Results

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Partners Value Investments L.P. (the “Partnership”, TSX: PVF.UN TSX:PVF.PR.U) announced today its financial results for the year ended December 31, 2024. All amounts are stated in U.S. dollars. The Partnership recorded net income of $74 million for the year ended December 31, 2024, compared to $15 million in […]

Culture

55 h. ago Rupert Resources Reports Audited Financial Results for the Ten Months Ending December 31, 2024

TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Rupert Resources Ltd (“Rupert” or the “Company”) announces that it has published its audited financial results for the ten months ending December 31, 2024 and accompanying Management’s Discussion and Analysis for the same period. Both of the above have been posted on the Company’s website www.rupertresources.com and on […]

Other

65 h. ago Aptose Reports Year End 2024 Results and Corporate Highlights

Tuspetinib Triple Drug Frontline Therapy Advancing in TUSCANY Clinical Trial Results to Date Highlight TUS Potential as an Ideal Third Drug to Include in AML Triplet Therapy Aptose Signs Debt Conversion Agreement with Hanmi SAN DIEGO and TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), […]

Other

66 h. ago Atlantic International Corp. Reports Strong 2024 Results with Over $442 Million in Revenue; Over 10% Revenue Growth

Company Completes First Quarter Publicly-Traded on Nasdaq Global Market under “ATLN” Announces Strategic Developments and Outlook; Targets $1 to $1.5 Billion Revenue from Both Organic Growth and M&A Initiatives in the Next 12 to 18 Months ENGLEWOOD CLIFFS, N.J., March 28, 2025 (GLOBE NEWSWIRE) — Atlantic International Corp. (“Atlantic” or the “Company”) (NASDAQ: ATLN), a leading […]

Society

69 h. ago Quantum Biopharma’s 2024 Financial Statements Show Strong Improvements in Cash, Working Capital, Operating Efficiency and the Removal of Material Uncertainty Related to Going Concern

Completion of unbuzzd™ Clinical Trial and Multiple Sclerosis Drug Lucid-21-302 Phase 1 Trial Advance Company’s Pipeline of Products and Assets TORONTO, March 28, 2025 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), has reported its financial and operational results for the fourth quarter and year ended December […]

Economics

3 d. ago Melcor REIT Announces Leading Independent Proxy Advisor Recommends Unitholders Vote for the Plan of Arrangement

In issuing its endorsement, ISS cites large premium cash exit, downside risks of non-approval, and meaningful improvements to the transaction Unitholders who have questions or need assistance in voting should contact Laurel Hill Advisory Group by telephone at 1-877-452-7184 (North American Toll Free) or 1-416- 304-0211 (Outside North America), or by email at assistance@laurelhill.com EDMONTON, […]

Other

3 d. ago DLC Releases Annual 2024 Results; Achieves Annual Funded Volumes of $67.4 Billion (19% Increase over Prior Year)

VANCOUVER, British Columbia, March 27, 2025 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSX:DLCG) (“DLCG” or the “Corporation”) is pleased to report its financial results for the three months (“Q4-2024”) and year ended December 31, 2024 (“annual”). For complete information, readers should refer to the annual audited consolidated financial statements and management discussion and analysis […]

Economics

3 d. ago NowVertical Group Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Financial Update Webinar

TORONTO, March 27, 2025 (GLOBE NEWSWIRE) — NowVertical Group Inc. (TSXV: NOW) (“NowVertical” or the “Company”), a leading data and AI solutions provider, will announce its 2024 fourth quarter and full year financial results before the market open on Wednesday, April 2, 2025. This will be followed by a webinar at 10:00 AM ET (7:00 […]

Culture

3 d. ago American Hotel Income Properties REIT LP to Host Fourth Quarter 2024 Results Conference Call on April 1, 2025

VANCOUVER, British Columbia, March 27, 2025 (GLOBE NEWSWIRE) — American Hotel Income Properties REIT LP (“AHIP”, “the Company”) (TSX: HOT.UN, TSX: HOT.U, TSX: HOT.DB.V) announces today that it intends to release its financial results for the quarter ended December 31, 2024 after market close on Monday, March 31, 2025. Interested parties are invited to participate […]

Culture

3 d. ago Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 2025 Reviewing pipeline and development plans for HBV programs Continued focus on efficient deployment of financial resources and personnel – terminated ATM program and implemented reduction of workforce by 57% […]

Culture

3 d. ago Spectral Medical Announces Fourth Quarter and Fiscal 2024 Results and Provides Corporate Update

154 patients enrolled TORONTO, March 27, 2025 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter and for the year ended December 31, 2024 and provided a corporate update. The Company […]

Culture

4 d. ago Sierra Metals Reports Strong Fourth Quarter and Full Year 2024 Financial and Operating Results

Full Year 2024 Highlights Record revenue of $272 million, an increase of 19% over 2023 Adjusted EBITDA of $74.2 million, a 40% increase compared to 2023 Exceeded 2024 annual production guidance AISC at both mines were below 2024 guidance Cash and cash equivalents of $19.8 million at year end, compared to $9.1 million at the […]

Culture

4 d. ago CEMATRIX Announces 2024 Fourth Quarter and Full Year 2024 Financial Results

CALGARY, Alberta, March 26, 2025 (GLOBE NEWSWIRE) — CEMATRIX Corporation (TSX: CEMX) (OTCQB: CTXXF) (“CEMATRIX” or the “Company“) a specialty construction contractor that produces cellular concrete solutions on site and is a leading manufacturer and supplier of cellular concrete in North America announced the release of its consolidated financial results for the quarter and year […]

Culture

4 d. ago AngloGold Ashanti Publishes Its 2024 UK Annual Report and Other Annual Reports

LONDON & DENVER & JOHANNESBURG — Today the Company published the following reports for the financial year ended 31 December 2024: 2024 UK Annual Report (including its audited consolidated financial statements as of and for the financial year ended 31 December 2024); Sustainability Report 2024; and Mineral Resource and Mineral Reserve Report 2024. These reports […]

Other

4 d. ago Digi Power X to Announce 2024 Year End Financial Results on March 31st

MIAMI, March 26, 2025 (GLOBE NEWSWIRE) — Digi Power X Inc. (“Digi Power X” or the “Company”) (Nasdaq: DGXX / TSXV: DGX), an innovative energy infrastructure company that develops cutting-edge data centers, plans to announce its financial results for the fourth quarter and year ended December 31, 2024 after markets close on March 31, 2025. […]

Other

5 d. ago Kelso Technologies Inc. Financial Results for the Year Ended December 31, 2024

WEST KELOWNA, British Columbia and BONHAM, Texas, March 25, 2025 (GLOBE NEWSWIRE) — Kelso Technologies Inc. (“Kelso” or the “Company”),(TSX: KLS) reports that the Company has released the audited consolidated financial statements and Management Discussion and Analysis for the year ended December 31, 2024. The audited year-end financial statements were prepared in accordance with International […]

Other

5 d. ago Quadravest Preferred Split Share ETF Financial Results to December 31, 2024

TORONTO, March 25, 2025 (GLOBE NEWSWIRE) — Quadravest Preferred Split Share ETF (“Preferred ETF”) announces that its annual financial statements and management report of fund performance for the period ended December 31, 2024 are now available at www.sedarplus.com and Preferred ETF’s website at www.quadravest.com. For further information, please contact Investor Relations at 416-304-4443, toll free […]

Other

5 d. ago BitFuFu Announces Full Year 2024 Unaudited Financial Results

SINGAPORE, March 25, 2025 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a global leader in Bitcoin mining and comprehensive mining services, today announced its unaudited financial results for the full year ended December 31, 2024. Full Year 2024 Financial Highlights Total revenue was US$463.3 million in 2024, representing an increase of […]

Other